Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00524186 Information provided by Roswell Park Cancer Institute

First Received on August 31, 2007. Last Updated on May 30, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Esophageal Cancer
Gastric Cancer

Additional conditions recognized in this trial

Esophageal Diseases
Esophageal Neoplasms
Stomach Neoplasms

More general conditions related to this trial

Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Stomach Diseases

Interventions listed in this trial

fluorouracil
irinotecan hydrochloride
leucovorin calcium
sunitinib malate
flow cytometry
pharmacological study

Additional drug interventions recognized in this trial

Camptothecin
Irinotecan
Leucovorin
Levoleucovorin
Sunitinib

Sponsors listed in this trial

Roswell Park Cancer Institute

Back to top of Main Content